|
ZFYVE26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.23640000249515E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.14449999997358E-07 |
| Normal-vs-Stage2 |
1.204160E-03 |
| Normal-vs-Stage3 |
3.67789999999868E-06 |
| Normal-vs-Stage4 |
2.38919999995257E-06 |
| Stage1-vs-Stage2 |
7.377400E-01 |
| Stage1-vs-Stage3 |
6.038600E-01 |
| Stage1-vs-Stage4 |
2.661000E-01 |
| Stage2-vs-Stage3 |
5.159600E-01 |
| Stage2-vs-Stage4 |
2.288000E-01 |
| Stage3-vs-Stage4 |
5.116200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.42340000014651E-07 |
| Normal-vs-AfricanAmerican |
1.292050E-02 |
| Normal-vs-Asian |
8.553500E-04 |
| Caucasian-vs-AfricanAmerican |
5.842200E-01 |
| Caucasian-vs-Asian |
7.681200E-01 |
| AfricanAmerican-vs-Asian |
7.701400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.15990000054889E-07 |
| Normal-vs-Female |
3.36980000015252E-07 |
| Male-vs-Female |
4.641200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.49599999999828E-05 |
| Normal-vs-Age(41-60Yrs) |
4.59629999949307E-07 |
| Normal-vs-Age(61-80Yrs) |
4.16599999997214E-06 |
| Normal-vs-Age(81-100Yrs) |
1.375400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.375800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.812000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.058400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.882800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.698600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.738200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.803800E-01 |
| Classical-VS-Follicular |
4.372200E-04 |
| Classical-VS-Other |
4.869600E-02 |
| Classical-VS-Normal |
1.91537999999492E-05 |
| Tall-VS-Follicular |
2.081200E-01 |
| Tall-VS-Other |
1.452210E-01 |
| Tall-VS-Normal |
1.102090E-03 |
| Follicular-VS-Other |
4.602800E-01 |
| Follicular-VS-Normal |
2.16329999469522E-08 |
| Other-VS-Normal |
2.424800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.60790000051037E-07 |
| Normal-vs-N1 |
2.28299999999182E-05 |
| N0-vs-N1 |
4.744200E-01 |
|
|
